Stay updated on Pembrolizumab for Advanced Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Advanced Uveal Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab for Advanced Uveal Melanoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedA new Locations section is added, listing Illinois and Tennessee study sites (Illinois and Tennessee), consolidating location details.SummaryDifference0.3%

- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedPubMed publications note updated to say they are automatically filled from PubMed, and the revision indicator now shows v3.3.2 (replacing v3.2.0).SummaryDifference0.1%

- Check49 days agoChange DetectedThe government funding lapse banner at the top of the ClinicalTrials.gov page has been removed, a non-significant change that does not affect study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check63 days agoChange DetectedNo significant changes to core study information (eligibility criteria, endpoints, enrollment, or contacts); only minor visual/layout tweaks to the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check93 days agoChange DetectedNew operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.SummaryDifference3%

- Check100 days agoChange DetectedUpgrade applied: version updated from v3.0.2 to v3.1.0. No other substantive content changes detected.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Advanced Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Advanced Uveal Melanoma Clinical Trial page.